未找到相关数据
Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).
被引：0
作者：
Dizman, Nazli
Govindarajan, Ameish
Zengin, Zeynep Busra
Meza, Luis A.
Tripathi, Nishita
Sayegh, Nicolas
Castro, Daniela V.
Chan, Elyse H.
Lee, Kyle O.
Prajapati, Sweta R.
Feng, Matthew I.
Loo, Vivian
Pace, Makala
O'brien, Shea
Bailey, Erin B.
Barragan-Carrillo, Regina
Chehrazi-Raffle, Alex
Li, Xiaochen
Agarwal, Neeraj
Pal, Sumanta Monty
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Belisario Dominguez Secc 16, Mexico City, Mexico
[5] City Hope Natl Med Ctr, Duarte, CA USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
678
引用
收藏
页数：1
相关论文